Mehmet Toner | |
---|---|
Born | 1958 (age 65–66) |
Nationality | Turkish American |
Alma mater | MIT ITU |
Awards | American Institute for Medical and Biological Engineering, National Academy of Inventors, National Academy of Engineering, National Academy of Medicine. |
Scientific career | |
Fields | Cryobiology, Biomedical Engineering |
Institutions | Harvard Medical School, Massachusetts Institute of Technology, Massachusetts General Hospital |
Doctoral advisor | Ernest G. Cravalho |
Notable students | Albert Folch, Sangeeta Bhatia, Alexander Revzin |
Mehmet Toner (born 1958) is a Turkish biomedical engineer. He is currently the Helen Andrus Benedict Professor of Surgery at Massachusetts General Hospital (MGH) and Harvard Medical School, [1] with a joint appointment as professor at the Harvard-MIT Division of Health Sciences and Technology (HST). [2]
Toner is a co-founder and Associate Director of the Center for Engineering in Medicine (CEM) at MGH and Director of the Biomedical Engineering Research and Education Program at MGH. He is one of the Senior Scientific Staff of the Shriners Hospital for Children. He is the founding director of the National Institute of Health's BioMicroElectroMechanical Systems or BioMEMS Resource Center at MGH. [3]
Toner has made contributions to the fields of cryobiology and biopreservation and to the wider field of biomedical engineering. [4] He has developed techniques in microtechnology and nanotechnology for use in clinical medicine, including the treatment of cancer. [5] He has been elected to the American Institute for Medical and Biological Engineering (AIMBE), [6] the National Academy of Inventors (NAI), the National Academy of Engineering (NAE), [7] and the National Academy of Medicine. [8]
Toner was born in Istanbul, Turkey in 1958. [5] He obtained his Bachelor of Science in mechanical engineering at the Istanbul Technical University in 1983, and his master's degree in mechanical engineering at MIT in 1985. Next Toner studied medical engineering [3] with Ernest G. Cravalho [9] at the Harvard–MIT Division of Health Sciences and Technology (HST), completing his Ph.D. in 1989. [3] He completed postdoctoral work under Martin Yarmush and Ronald G. Tompkins at MGH. [10]
In 1989 Toner joined the faculty of Massachusetts General Hospital (MGH) and became an Assistant Professor in Biomedical Engineering at Harvard Medical School. He became an Associate Professor in 1996, and a Professor in 2002. He is jointly appointed as a Professor of Health Sciences and Technology for the Harvard–MIT Program in Health Sciences and Technology. [3] [5]
In 1995 Toner co-founded the Center for Engineering in Medicine (CEM) at MGH. becoming its associate director. That year, he also founded the Biomedical Engineering Research and Education Program at MGH, becoming its director. In 2004, he became founding director of the NIH BioMicroElectroMechanical Systems (BioMEMS) Resource Center at MGH. [11]
In 1999, Toner helped to found the Annual Review of Biomedical Engineering , serving as associate editor. [5] As of 2021, Toner became co-editor of the Annual Review of Biomedical Engineering, sharing the position with Martin L. Yarmush. [12]
Toner's early work focused on understanding cellular injuries during cryopreservation and finding optimum strategies for cell preservation. [13] Toner developed a theory of intra-cellular ice formation while completing his PhD in Medical Engineering at the Harvard-MIT Division of Health Sciences and Technology at Massachusetts Institute of Technology (MIT). As part of that work, he proposed acetylated trehalose as a novel cryoprotectant. [14] [15]
Toner's later work includes bio-sensing, regenerative medicine, and tissue engineering. He has helped to develop microelectromechanical and microfluidic devices for point-of-care detection of cancer, AIDS, genetic defects and infectious diseases. [7] He has received awards for the development of the CTC-chip, a microchip which can isolate and detect circulating tumor cells in peripheral blood. [16] [5] During the COVID-19 pandemic, Toner worked with scientists at several institutions to develop a fast, reliable test for SARS-CoV-2 virus. [17]
Robert Samuel Langer Jr. FREng is an American biotechnologist, businessman, chemical engineer, chemist, and inventor. He is one of the nine Institute Professors at the Massachusetts Institute of Technology.
The Harvard–MIT Program in Health Sciences and Technology, or HST, is one of the oldest and largest biomedical engineering and physician-scientist training programs in the United States. It was founded in 1970 and is the longest-standing collaboration between Harvard University and the Massachusetts Institute of Technology (MIT). Within the program, graduate and medical students are registered with both MIT and Harvard and may work with faculty and affiliated faculty members from both communities. HST is a part of MIT's Institute for Medical Engineering and Science and forms the London Society at Harvard Medical School.
Ali Khademhosseini is an Iranian-born Canadian-American engineer. He is the CEO of the Terasaki Institute, non-profit research organization in Los Angeles, and Omeat Inc., a cultivated-meat startup. Before taking his current CEO roles, he spent one year at Amazon Inc. Prior to that he was the Levi Knight chair and professor at the University of California-Los Angeles where he held a multi-departmental professorship in Bioengineering, Radiology, Chemical, and Biomolecular Engineering as well as the Director of Center for Minimally Invasive Therapeutics (C-MIT). From 2005 to 2017, he was a professor at Harvard Medical School, and the Wyss Institute for Biologically Inspired Engineering.
Utkan Demirci is a tenured professor and a successful serial academic entrepreneur at Stanford University at the departments of Radiology and Electrical Engineering. He served as the Interim Division Chief and Director of the Canary Center at Stanford for Cancer Early Detection in the Department of Radiology.
Cato T. Laurencin FREng SLMH is an American engineer, physician, scientist, innovator and a University Professor of the University of Connecticut.
Bin He is a Chinese American biomedical engineering scientist. He is the Trustee Professor of the Department of Biomedical Engineering, professor by courtesy in the Department of Electrical and Computer Engineering, and Professor of Neuroscience Institute, and was the head of the department of Biomedical Engineering at Carnegie Mellon University. Prior, he was Distinguished McKnight University Professor of Biomedical Engineering and Medtronic-Bakken Endowed Chair for Engineering in Medicine at the University of Minnesota. He previously served as the director of the Institute for Engineering in Medicine and the Center for Neuroengineering at the University of Minnesota. He was the Editor in Chief of the IEEE Transactions on Biomedical Engineering and serves as the editor in chief of IEEE Reviews in Biomedical Engineering. He was the president of the IEEE Engineering in Medicine & Biology Society (EMBS) from 2009 to 2010 and chair of International Academy of Medical and Biological Engineering from 2018 to 2021.
Sangeeta N. Bhatia is an American biological engineer and the John J. and Dorothy Wilson Professor at MIT’s Institute for Medical Engineering and Science and Electrical Engineering and Computer Science (EECS) at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, United States. Bhatia's research investigates applications of micro- and nano-technology for tissue repair and regeneration. She applies ideas from computer technology and engineering to the design of miniaturized biomedical tools for the study and treatment of diseases, in particular liver disease, hepatitis, malaria and cancer.
Linda Gay Griffith is an American biological engineer, and Professor of Biological Engineering and Mechanical Engineering at Massachusetts Institute of Technology, where she also directs the Center for Gynepathology Research.
Gordana Vunjak-NovakovicFRSC is a Serbian American biomedical engineer and university professor. She is a University Professor at Columbia University, as well as the Mikati Foundation Professor of Biomedical Engineering and Medical Sciences. She also heads the laboratory for Stem Cells and Tissue Engineering at Columbia University. She is part of the faculty at the Irving Comprehensive Cancer Center and the Center for Human Development, both found at Columbia University. She is also an honorary professor at the Faculty of Technology and Metallurgy at the University of Belgrade, an honorary professor at the University of Novi Sad, and an adjunct professor at the Department of Biomedical Engineering at Tufts University.
Albert Folch Folch is a Spanish/Catalan scientist, writer, and artist. He is the son of editor Xavier Folch and sinologist Dolors Folch. He is currently a professor in the Department of Bioengineering at the University of Washington who is known for his research into Microfluidics and BioMEMS as well as his works of scientific art.
Martin (Maish) L. Yarmush is an academic, American scientist, physician, and engineer known for his work in biotechnology and bioengineering. His faculty career began in 1984 at MIT in the Department of Chemical Engineering as a Principal Research Associate and Lucille P. Markey Scholar in Biomedical Science. In 1988 he joined Rutgers University, as Professor of Chemical and Biochemical Engineering and a member of the Center of Advanced Biotechnology and Medicine. In 1995, he returned to the Boston area to serve as the Helen Andrus Benedict Professor of Surgery and Bioengineering in the Harvard-MIT Division of Health Sciences and Technology, and to establish the Center for Engineering in Medicine at the Harvard Affiliated Teaching Hospitals. In 2007 he returned to Rutgers to hold the Paul and Mary Monroe Endowed Chair in Science and Engineering and serve as Distinguished Professor in the Department of Biomedical Engineering. He also holds a Lecturer in Surgery and Bioengineering position at Harvard Medical School, and is a member of the Senior Scientific Staff at the Shriners children's hospital in Boston.
Samir Mitragotri is an Indian American professor at Harvard University, an inventor, an entrepreneur, and a researcher in the fields of drug delivery and biomaterials. He is currently the Hiller Professor of Bioengineering and Hansjörg Wyss Professor of Biologically Inspired Engineering at Harvard John A. Paulson School of Engineering and Applied Sciences and the Wyss Institute for Biologically Inspired Engineering. Prior to 2017, he was the Duncan and Suzanne Mellichamp Chair Professor at University of California, Santa Barbara.
Ravi V. Bellamkonda is an Indian-American biomedical engineer and academic administrator. Since 2021, he has served as Provost and Executive Vice President for Academic Affairs at Emory University in Atlanta, Georgia. Bellamkonda was previously Vinik Dean of the Pratt School of Engineering at Duke University. Pending approval by the Board of Trustees, he will serve as Provost and Executive Vice President for Academic Affairs at The Ohio State University in Columbus, Ohio, effective January 14, 2025.
Sina Y. Rabbany is the Jean Nerken Distinguished Professor of Engineering at Hofstra University, dean of the Fred DeMatteis School of Engineering and Applied Science, founding director of the school's Bioengineering program, and adjunct associate professor of bioengineering at the Weill Cornell Medical College of Cornell University. Under his tenure, the DeMatteis School's fast growth led to the school's planned expansion into a new Science and Innovation Center. His research concerns cellular and tissue engineering of the vascular system and investigates the impact of the biophysical microenvironment on the structure and function of endothelial cells. His research explores the capabilities of endothelial cells to build functional blood vessels and support organ regeneration. His h-index is 28 by Google Scholar.
Lim Chwee Teck is a Singaporean researcher and entrepreneur. He is a specialist in human disease mechanobiology and in developing medical and wearable technologies for disease diagnosis and precision therapy and bringing them from the laboratory to the bedside.
Vadim Backman is an American biomedical engineer and the Sachs Family Professor of biomedical engineering at the Robert R. McCormick School of Engineering and Applied Science at Northwestern University. He is also a Professor of Medicine (Hematology/Oncology) and Professor of Biochemistry and Molecular Genetics at Feinberg School of Medicine and is the Associate Director of Research Technology and Infrastructure and Program Leader in Cancer and Physical Sciences at Robert H. Lurie Comprehensive Cancer Center.
Umut Atakan Gurkan is a Turkish–American mechanical and biomedical engineer. As the Wilbert J. Austin Professor of Engineering at Case Western Reserve University, Gurkan investigates hemoglobin, red blood cells, blood rheology and microcirculation in health and disease and with targeted therapies and gene-based cures.
Pavlos P. Vlachos is a Greek-American engineer, scientist, academic, and entrepreneur. He is professor in Purdue’s School of Mechanical Engineering and in the Weldon School of Biomedical Engineering, and the St. Vincent Health Professor of Healthcare Engineering. He serves as the Director for the Purdue Regenstrief Center for Healthcare Engineering (RCHE).
Claudia Fischbach is a German bioengineer who serves as the James M. and Marsha McCormick Director of Biomedical Engineering and the Stanley Bryer 1946 Professor of Biomedical Engineering at Cornell University. She is Director of the Cornell Physical Sciences Oncology Center on the Physics of Cancer Metabolism.
Kenneth Lutchen is a biomedical engineer, researcher, professor, and university leader. He was named university provost and chief academic officer ad interim of Boston University in July 2023.